Experimental lymphoma combo trial halted early
NCT ID NCT04425070
First seen Jan 10, 2026 · Last updated May 09, 2026 · Updated 18 times
Summary
This study tested a drug called selinexor combined with chemotherapy or another drug (tislelizumab) in 56 adults with relapsed or hard-to-treat T-cell or NK-cell lymphoma. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Cancer Hospital
Hefei, Anhui, 230031, China
-
Beijing Tongren Hospital.CMU
Beijing, Beijing Municipality, 100005, China
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400030, China
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, 530021, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, 210000, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210029, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
Tianjin Medical Universisity Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300060, China
Conditions
Explore the condition pages connected to this study.